These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2053154)

  • 1. The significance and implications of hepatitis B infection in renal transplant recipients.
    Dhar JM; al-Khader AA; al-Sulaiman MH; al-Hasani MK
    Transplant Proc; 1991 Apr; 23(2):1785-6. PubMed ID: 2053154
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B and renal transplantation.
    Scott D; Mijch A; Lucas CR; Marshall V; Thomson N; Atkins R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2159-60. PubMed ID: 3274482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival in living related donor renal allograft recipients with hepatitis B infection.
    Roy DM; Thomas PP; Dakshinamurthy KV; Jacob CK; Shastry JC
    Transplantation; 1994 Jul; 58(1):118-9. PubMed ID: 8036701
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of donor hepatitis B antigenemia on renal allograft in hepatitis B recipients.
    Chen JB; Hsieh H; Hsu KT; Chen CH
    Transplant Proc; 1996 Jun; 28(3):1490-2. PubMed ID: 8658755
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcome of HBsAg(+) renal allograft recipients.
    Kang SW; Lee SW; Choi KH; Han KH; Lee HY; Han DS; Kim YS; Park K
    Transplant Proc; 1996 Jun; 28(3):1653-4. PubMed ID: 8658823
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Rowińska D; Kozłowska-Boszko B; Rowiński W; Szmidt J; Lao M
    Transplant Proc; 1996 Dec; 28(6):3459-60. PubMed ID: 8962347
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience.
    Santos L; Alves R; Macario F; Parada B; Campos M; Mota A
    Transplant Proc; 2009 Apr; 41(3):880-2. PubMed ID: 19376378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B in renal transplant patients.
    Peres AA; Dias EA; Chesky M; Alvares-da-Silva MR; Jobim LF; Gonçalves LF; Manfro RC
    Transpl Infect Dis; 2005 Jun; 7(2):51-6. PubMed ID: 16150090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of hepatitis B core antibody positivity in donors for liver transplantation in Saudi Arabia.
    Al-Sebayel MI; Khalaf HA; Ramirez CG
    Saudi Med J; 2002 Mar; 23(3):298-300. PubMed ID: 11938420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of hepatitis B infection on the outcome of renal allotransplantation.
    Flagg GL; Silberman H; Takamoto SK; Berne TV
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2155-8. PubMed ID: 3547916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings.
    Veroux M; Puliatti C; Macarone M; Cappello D; Gagliano M; Spataro M; Di Mare M; Giuffrida G; Veroux P
    Transplant Proc; 2005; 37(6):2467-8. PubMed ID: 16182711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal transplantation in Saudi Arabia.
    Hefty TR; Barry JM
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):10-2. PubMed ID: 3520998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus in Saudi Arabia.
    el-Hazmi MA
    J Trop Med Hyg; 1989 Feb; 92(1):56-61. PubMed ID: 2918579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
    Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal immunosuppressive regimen for hepatitis B-positive kidney transplant recipients.
    Hsieh H; Chen CH; Huang HF; Tseng YJ
    Transplant Proc; 1996 Jun; 28(3):1495-7. PubMed ID: 8658757
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of hepatitis B and C virus on kidney transplantation outcome.
    Mathurin P; Mouquet C; Poynard T; Sylla C; Benalia H; Fretz C; Thibault V; Cadranel JF; Bernard B; Opolon P; Coriat P; Bitker MO
    Hepatology; 1999 Jan; 29(1):257-63. PubMed ID: 9862875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
    Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of renal transplantation in hepatitis BsAg-positive patients.
    Nelson SR; Snowden SA; Sutherland S; Smith HM; Parsons V; Bewick M
    Nephrol Dial Transplant; 1994; 9(9):1320-3. PubMed ID: 7816299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey on the prevalence and management of hepatitis B after renal transplantation in Asian-Pacific countries.
    Chan TM; Chapman J; Lee CJ; Morad Z; Ona ET; Park K; Pingle A; Rizvi SA; Shaheen FA; Sumethkul V; Tang XD; Watarai Y
    Transplant Proc; 2004 Sep; 36(7):2126-7. PubMed ID: 15518771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.